Similarly, tissue uptake in GRPR-expressing regions was also reduced: tumor (5.4 ± 1%IA/g), pancreas (1.9 ± 0.1%IA/g), stomach (1.4 ± 0.2%IA/g), and small intestine (0.6 ± 0.1%IA/g) [22]. This evidence concerns the gene GRPR and neoplasm.